rs11539445
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001040436.3(YARS2):c.572G>T(p.Gly191Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.135 in 1,613,962 control chromosomes in the GnomAD database, including 15,104 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001040436.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
YARS2 | NM_001040436.3 | c.572G>T | p.Gly191Val | missense_variant | 1/5 | ENST00000324868.13 | NP_001035526.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
YARS2 | ENST00000324868.13 | c.572G>T | p.Gly191Val | missense_variant | 1/5 | 1 | NM_001040436.3 | ENSP00000320658 | P1 | |
YARS2 | ENST00000548490.1 | c.494G>T | p.Gly165Val | missense_variant, NMD_transcript_variant | 1/5 | 5 | ENSP00000447710 |
Frequencies
GnomAD3 genomes AF: 0.141 AC: 21485AN: 152048Hom.: 1552 Cov.: 32
GnomAD3 exomes AF: 0.123 AC: 30883AN: 250954Hom.: 2031 AF XY: 0.125 AC XY: 17035AN XY: 135816
GnomAD4 exome AF: 0.134 AC: 196140AN: 1461796Hom.: 13548 Cov.: 34 AF XY: 0.134 AC XY: 97709AN XY: 727200
GnomAD4 genome AF: 0.141 AC: 21489AN: 152166Hom.: 1556 Cov.: 32 AF XY: 0.139 AC XY: 10331AN XY: 74390
ClinVar
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | This variant is associated with the following publications: (PMID: 30026338, 29300242, 26647310, 24344687) - |
Benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Feb 22, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Myopathy, lactic acidosis, and sideroblastic anemia 2 Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Myopathy, lactic acidosis, and sideroblastic anemia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at